Proactive Investors - Run By Investors For Investors

Zelda Therapeutics' Dr. Stewart Washer discusses medical cannabis achievements

Zelda is also building a pre-clinical research portfolio targeting cancer.
Zelda Therapeutics' Dr. Stewart Washer discusses medical cannabis achievements
Cannabis contains at least 85 types of cannabinoids

Zelda Therapeutics Ltd (ASX: ZLD) has secured exclusive, global access to an extensive set of human data related to medicinal cannabis based formulations and treatment protocols.

This human data has been generated over several years by a California-based group (Aunt Zelda’s) that has a high profile within the U.S. which is also growing internationally.

The company has a deep knowledge of the scientific rationale for certain cannabis-based formulations and protocols to treat a variety of medical conditions.

Zelda has embarked on a program of human clinical trials.

WATCH NOW: Zelda half-year review by Stewart Washer, executive director

Zelda is scheduled to release its financial statements to the ASX on Wednesday 30 August 2017.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Related Articles

cannabis plant
May 06 2019
The cannabis company invests in income-producing property and provides financing solutions and capital investment to service the blossoming cannabis industry
Sydney Harbour Bridge
January 23 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.
cannabis bud on tray
April 25 2019
Armed with a new partnership with Canada's largest pharmacy and an international cultivator, Flowr is aiming to provide medicinal and recreational consumers around the world with premium, high-quality cannabis

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use